ACE2 g1 + Cas9 Citations (1)

Originally described in: CRISPR plasmids to knock out SARS-CoV-2 host genes
Unpublished

Articles Citing ACE2 g1 + Cas9

Articles
Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry. Joensuu M, Syed P, Saber SH, Lanoue V, Wallis TP, Rae J, Blum A, Gormal RS, Small C, Sanders S, Jiang A, Mahrhold S, Krez N, Cousin MA, Cooper-White R, Cooper-White JJ, Collins BM, Parton RG, Balistreri G, Rummel A, Meunier FA. EMBO J. 2023 Jul 3;42(13):e112095. doi: 10.15252/embj.2022112095. Epub 2023 May 25. PubMed Associated Plasmids pLV-hUV6-sgRNA-dCas9-KRAB-TagBFP2 (identifier AAAA-0244) pLV-RnSyt1-sgRNA1-dCas9-KRAB-TagBFP2 (identifier AAAA-0245) pLV-RnSyt1-sgRNA2-dCas9-KRAB-TagBFP2 (identifier AAAA-0246) pLV-RnSyt1-sgRNA3-dCas9-KRAB-TagBFP2 (Identifier AAAA-0247)

If you have published an article using this material, please email us at [email protected] to have your article added to this page.